Potassium Iodide in the treatment of recurrent staphylococcal skin infections
Original title: Yoduro potásico en el tratamiento de la estafilococcia recurrente de la piel
Med Cutan Iber Lat Am 2006; 34 (2): 57-62
An open clinical study was performed to know the therapeutic value of the potassium Iodide administered in saturated solution form ( SSKI ) for the treatment of recurrent staphylococcal skin infections. The included cases presented three clinical forms of the infection: 16 cases of folliculitis, 10 cases with furuncles and 4 cases with carbuncle. To be included the patients they should behave an affection of three or more years of evolution and to have six or more annual relapses in those a treatment with systemic Antibiotic should be used. The SSKI was administered to a concentration of 47 mg/drop during 12 months to an initial dose of 1.41 g/day, increasing 0,705 mg every 6-7 days until a daily dose of 4.23 g/day. In the first consultation it was also used a treatment with systemic and topic Antibiotics . The relapses disappeared and the therapy with systemic Antibiotics were not necessary after the second month of treatment. Relapses of the infection were not observed in the following months as neither after 12 months after having concluded the treatment. Adverse reactions were not observed by the employment of SSKI during the two years of follow-up. It is considered that the SSKI is useful for the treatment of recurrent staphylococcal skin infections. The SSKI does not create bacterial resistance and it preserves the employment of antibiotics for other more serious infections.